Setting the stage for more Resilia TAVR procedures in 2024
Last year, under the recommendation and guidance of Neil E. Strickman, MD, FACC, FSCAI, FACP, an 81-year-old woman in Houston received the first TAVR procedure using the “Resilia” coating that prevents calcification of the leaflets of the valve and decreases degeneration of the valve. The success of this inaugural Resilia TAVR procedure in our city gives us confidence as we begin to offer this procedure to more patients in 2024.
This groundbreaking advancement provides improved outcomes and longevity for high surgical-risk patients, and we are excited to continue our endless drive for the forward progression of medicine and begin implementing Resilia at Baylor St. Luke’s Medical Center.